Home Cart 0 Sign in  
X

[ CAS No. 50-84-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 50-84-0
Chemical Structure| 50-84-0
Chemical Structure| 50-84-0
Structure of 50-84-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 50-84-0 ]

Related Doc. of [ 50-84-0 ]

Alternatived Products of [ 50-84-0 ]

Product Details of [ 50-84-0 ]

CAS No. :50-84-0 MDL No. :MFCD00002414
Formula : C7H4Cl2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :ATCRIUVQKHMXSH-UHFFFAOYSA-N
M.W : 191.01 Pubchem ID :5787
Synonyms :

Calculated chemistry of [ 50-84-0 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.42
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.46 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.5
Log Po/w (XLOGP3) : 2.82
Log Po/w (WLOGP) : 2.69
Log Po/w (MLOGP) : 2.79
Log Po/w (SILICOS-IT) : 2.5
Consensus Log Po/w : 2.46

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.14
Solubility : 0.139 mg/ml ; 0.000727 mol/l
Class : Soluble
Log S (Ali) : -3.26
Solubility : 0.105 mg/ml ; 0.000549 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.01
Solubility : 0.188 mg/ml ; 0.000986 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.28

Safety of [ 50-84-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 50-84-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 50-84-0 ]
  • Downstream synthetic route of [ 50-84-0 ]

[ 50-84-0 ] Synthesis Path-Upstream   1~20

  • 1
  • [ 50-84-0 ]
  • [ 544-92-3 ]
  • [ 7147-90-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1986, vol. 29, # 6, p. 947 - 959
  • 2
  • [ 50-84-0 ]
  • [ 94-99-5 ]
Reference: [1] Patent: CN106117028, 2016, A,
  • 3
  • [ 50-84-0 ]
  • [ 20443-99-6 ]
Reference: [1] Patent: CN106117028, 2016, A,
  • 4
  • [ 50-84-0 ]
  • [ 89-77-0 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1987, vol. 21, # 1, p. 34 - 45[2] Khimiko-Farmatsevticheskii Zhurnal, 1987, vol. 21, # 1, p. 38 - 49
[3] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 10, p. 171
  • 5
  • [ 50-84-0 ]
  • [ 79-19-6 ]
  • [ 28004-63-9 ]
Reference: [1] Bulletin of the Korean Chemical Society, 2010, vol. 31, # 8, p. 2345 - 2350
[2] Bulletin of the Korean Chemical Society, 2011, vol. 32, # 3, p. 1011 - 1016
[3] Journal of Chemical Research, 2009, # 11, p. 674 - 676
[4] Journal of Chemical Research, 2009, # 11, p. 671 - 673
[5] Journal of Chemical Research, 2010, vol. 34, # 12, p. 719 - 721
[6] Synthetic Communications, 2011, vol. 41, # 6, p. 864 - 870
[7] Journal of Chemical Research, 2011, vol. 35, # 8, p. 442 - 443
[8] Nucleosides, Nucleotides and Nucleic Acids, 2011, vol. 30, # 4, p. 280 - 292
[9] Asian Journal of Chemistry, 2012, vol. 24, # 6, p. 2739 - 2743
[10] European Journal of Medicinal Chemistry, 2015, vol. 93, p. 599 - 613
[11] Oriental Journal of Chemistry, 2015, vol. 31, # 4, p. 1873 - 1885
  • 6
  • [ 50-84-0 ]
  • [ 5292-39-7 ]
  • [ 652-12-0 ]
Reference: [1] Patent: US5523476, 1996, A,
  • 7
  • [ 50-84-0 ]
  • [ 201230-82-2 ]
  • [ 89-20-3 ]
  • [ 100-21-0 ]
  • [ 528-44-9 ]
  • [ 1967-31-3 ]
  • [ 74-11-3 ]
Reference: [1] Chemistry Letters, 1986, p. 299 - 302
  • 8
  • [ 50-84-0 ]
  • [ 19719-28-9 ]
Reference: [1] Patent: CN106117028, 2016, A,
  • 9
  • [ 50-84-0 ]
  • [ 6306-60-1 ]
Reference: [1] Patent: CN106117028, 2016, A,
  • 10
  • [ 50-84-0 ]
  • [ 57479-70-6 ]
Reference: [1] Patent: US5344968, 1994, A,
  • 11
  • [ 50-84-0 ]
  • [ 12775-96-1 ]
  • [ 57479-70-6 ]
Reference: [1] Patent: US4328155, 1982, A,
  • 12
  • [ 50-84-0 ]
  • [ 2736-23-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1974, vol. 17, p. 956 - 965
  • 13
  • [ 50-84-0 ]
  • [ 201230-82-2 ]
  • [ 89-20-3 ]
  • [ 100-21-0 ]
  • [ 528-44-9 ]
  • [ 1967-31-3 ]
  • [ 74-11-3 ]
Reference: [1] Chemistry Letters, 1986, p. 299 - 302
  • 14
  • [ 50-84-0 ]
  • [ 5106-98-9 ]
  • [ 56363-84-9 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1932, vol. 51, p. 98,109
  • 15
  • [ 50-84-0 ]
  • [ 124-41-4 ]
  • [ 5106-98-9 ]
  • [ 56363-84-9 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1932, vol. 51, p. 98,109
  • 16
  • [ 50-84-0 ]
  • [ 74-88-4 ]
  • [ 65410-80-2 ]
  • [ 83277-23-0 ]
Reference: [1] Patent: WO2004/89897, 2004, A1, . Location in patent: Page 19; 20; 26
  • 17
  • [ 50-84-0 ]
  • [ 1152981-12-8 ]
  • [ 519055-62-0 ]
YieldReaction ConditionsOperation in experiment
76% With dicobalt octacarbonyl; tert-butylisonitrile In acetonitrile at 80℃; for 4 h; 0.5 mmol (0.0955 g) of 2,5-dichlorobenzoic acid, 0.75 mmol (0.2011 g) of 2-bromothiophenesulfonyl azide and 0.025 mmol (0.0086 g) of octacarbyldicobalt were weighed, respectively.Add to a 25 mL reaction tube;Then, 4 mL of acetonitrile solvent, 100 μl of t-butyl isocyanide measured by a micro syringe was sequentially added to the above reactor, and the whole reaction system was stirred at 80 ° C for 4 hours;After the completion of the reaction, the mixture was concentrated by rotary evaporation, and the mixture was applied and separated by column chromatography (column separation conditions: 200-300 mesh silica gel powder, mobile phase ethyl acetate: petroleum ether = 1:4, yielding 0.1583 g The object product was obtained as a white solid in a yield of 76percent.
Reference: [1] Chemistry--A European Journal, 2012, vol. 18, # 45, p. 14444 - 14453,10
[2] Chemistry - A European Journal, 2012, vol. 18, # 45, p. 14444 - 14453
[3] Journal of Organic Chemistry, 2018, vol. 83, # 16, p. 9364 - 9369
[4] Patent: CN108558822, 2018, A, . Location in patent: Paragraph 0035; 0036; 0037; 0040; 0043
  • 18
  • [ 53595-65-6 ]
  • [ 50-84-0 ]
  • [ 519055-62-0 ]
YieldReaction ConditionsOperation in experiment
65% With dmap; 2-chloro-1-methyl-pyridinium iodide; triethylamine In dichloromethane at 20℃; for 1 h; DCM (2.0 mL) was added to a 20 mL vial containing DMAP (3.81 mg, 0.031 mmol), 2-chloro-1-methylpyridin-1-ium iodide (0.191 g, 0.748 mmol), 2,4-dichlorobenzoic acid (0.119 g, 0.623 mmol), 5-bromothiophene-2-sulfonamide (0.302 g, 1.25 mmol) at rt. After stirring for 5 min, TEA (0.261 ml, 1.869 mmol) was slowly added to the reaction mixture. The reaction was stirred at rt for 1 h. The reaction solvent was concentrated under vacuum and the crude residue was taken up in ethyl acetate, washed with 1N HCl (1 mL), water, and brine. The ethyl acetate layer was separated, dried (Na2SO4), filtered and concentrated. The crude material was purified by silica gel flash column chromatography eluting with ethyl acetate in hexane from 0 to 30percent to give the desired product (0.168 g, 65percent) as colorless crystals: 1H NMR (499 MHz, CDCl3) δ 7.73 (d, J = 4.1 Hz, 1H), 7.71 (d, J = 8.5 Hz, 1H), 7.45 (d, J = 1.9 Hz, 1H), 7.36 (dd, J = 8.5, 1.9 Hz, 1H), 7.14 (d, J = 4.1 Hz, 1H).
Reference: [1] Tetrahedron Letters, 2019, vol. 60, # 3, p. 268 - 271
  • 19
  • [ 53595-65-6 ]
  • [ 50-84-0 ]
  • [ 519055-62-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 3, p. 617 - 620
  • 20
  • [ 50-84-0 ]
  • [ 519055-62-0 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 19, p. 6302 - 6305
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 50-84-0 ]

Aryls

Chemical Structure| 50-79-3

[ 50-79-3 ]

2,5-Dichlorobenzoic acid

Similarity: 0.96

Chemical Structure| 7697-29-2

[ 7697-29-2 ]

4-Chloro-3-methylbenzoic acid

Similarity: 0.94

Chemical Structure| 15068-35-6

[ 15068-35-6 ]

2-Chloro-3-methylbenzoic acid

Similarity: 0.92

Chemical Structure| 51-36-5

[ 51-36-5 ]

3,5-Dichlorobenzoic acid

Similarity: 0.92

Chemical Structure| 74-11-3

[ 74-11-3 ]

4-Chlorobenzoic acid

Similarity: 0.91

Chlorides

Chemical Structure| 50-79-3

[ 50-79-3 ]

2,5-Dichlorobenzoic acid

Similarity: 0.96

Chemical Structure| 7697-29-2

[ 7697-29-2 ]

4-Chloro-3-methylbenzoic acid

Similarity: 0.94

Chemical Structure| 15068-35-6

[ 15068-35-6 ]

2-Chloro-3-methylbenzoic acid

Similarity: 0.92

Chemical Structure| 51-36-5

[ 51-36-5 ]

3,5-Dichlorobenzoic acid

Similarity: 0.92

Chemical Structure| 74-11-3

[ 74-11-3 ]

4-Chlorobenzoic acid

Similarity: 0.91

Carboxylic Acids

Chemical Structure| 50-79-3

[ 50-79-3 ]

2,5-Dichlorobenzoic acid

Similarity: 0.96

Chemical Structure| 7697-29-2

[ 7697-29-2 ]

4-Chloro-3-methylbenzoic acid

Similarity: 0.94

Chemical Structure| 15068-35-6

[ 15068-35-6 ]

2-Chloro-3-methylbenzoic acid

Similarity: 0.92

Chemical Structure| 51-36-5

[ 51-36-5 ]

3,5-Dichlorobenzoic acid

Similarity: 0.92

Chemical Structure| 74-11-3

[ 74-11-3 ]

4-Chlorobenzoic acid

Similarity: 0.91